Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progenitor Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06610773
What this trial is testing

HUC-MSC for Treatment of High-risk HPV Infection

Who this might be right for
Human Papillomavirus VirusesMesenchymal Stem Cells
Shanghai East Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00001873
What this trial is testing

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
National Heart, Lung, and Blood Institute (NHLBI) 102
Large-scale testing (Phase 3)Study completedNCT01539083
What this trial is testing

Velcade (Bortezomib) Consolidation After Transplant

Who this might be right for
Multiple Myeloma
Janssen Scientific Affairs, LLC 256
Testing effectiveness (Phase 2)Active Not RecruitingNCT04232241
What this trial is testing

Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid Leukemia in RemissionAcute Lymphoblastic Leukemia in RemissionMyelodysplastic Syndromes
Universitätsklinikum Hamburg-Eppendorf 167
Testing effectiveness (Phase 2)Looking for participantsNCT03214354
What this trial is testing

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

Who this might be right for
Sickle Cell DiseaseStem Cell Transplant ComplicationsRed Blood Cell Disorder+1 more
University of Calgary 12
Large-scale testing (Phase 3)UnknownNCT01694173
What this trial is testing

Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM

Who this might be right for
Type 2 Diabetes Mellitus
Post Graduate Institute of Medical Education and Research, Chandigarh 28
Early research (Phase 1)Study completedNCT01297205
What this trial is testing

Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia

Who this might be right for
Bronchopulmonary Dysplasia
Medipost Co Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT04926194
What this trial is testing

Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Myelodysplastic/Myeloproliferative NeoplasmSteroid Refractory GVHDAllogeneic Hematopoietic Cell Transplant
University Health Network, Toronto 1
Testing effectiveness (Phase 2)Study completedNCT04811651
What this trial is testing

Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke

Who this might be right for
Ischemic Stroke
General Hospital of Shenyang Military Region 156
Not applicableLooking for participantsNCT04997473
What this trial is testing

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

Who this might be right for
ObesityStem Cell Transplant
University of California, Los Angeles 20
Testing effectiveness (Phase 2)UnknownNCT02034669
What this trial is testing

Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment

Who this might be right for
Acute Spinal Cord Injury
Tri Phuoc Biotechnology., JSC 48
Not applicableUnknownNCT03684083
What this trial is testing

Inflammatory Response to Paramyxovirus Infection in an Ex-vivo Model of Bronchial Epithelial Cells in Allogeneic HSCT Recipients

Who this might be right for
Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 14
Not applicableStudy completedNCT04869254
What this trial is testing

Lymphocyte Count, ATG Dose and Incidence and Severity of GVHD in Pediatric Recipients of HSCT

Who this might be right for
Hematopoietic Stem Cell Transplantation
IRCCS Burlo Garofolo 102
Testing effectiveness (Phase 2)Study completedNCT01813188
What this trial is testing

Clinical Trial Based on the Use of Mononuclear Cells From Autologous Bone Marrow in Patients With Pseudoarthrosis

Who this might be right for
Pseudoarthrosis
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 5
Early research (Phase 1)Ended earlyNCT00278486
What this trial is testing

Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON)

Who this might be right for
Retinal Disease
Richard Burt, MD 2
Early research (Phase 1)Study completedNCT05362786
What this trial is testing

Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease

Who this might be right for
Chronic Kidney Diseases
LaTonya J. Hickson 14
Testing effectiveness (Phase 2)Looking for participantsNCT06461988
What this trial is testing

Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma

Who this might be right for
Multiple MyelomaPost Stem Cell Transplant
Stanford University 20
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)UnknownNCT03437603
What this trial is testing

Eltrombopag For Secondary Poor Graft Function Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Poor Graft Function
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Next Page